BİŞGİN, A. Et Al. 2009. Increased sTRAIL level following BevacizumAb treatment is correlated with patient survival in metastatic colon cancer. 34th FEBS Congress .

BİŞGİN, A., AYDIN ACAR, Ç., TERZİOĞLU, M. E., YALÇIN, A. D., KARGI, A., Savaş, B., ... ŞANLIOĞLU, S.(2009). Increased sTRAIL level following BevacizumAb treatment is correlated with patient survival in metastatic colon cancer . 34th FEBS Congress

BİŞGİN, ATIL Et Al. "Increased sTRAIL level following BevacizumAb treatment is correlated with patient survival in metastatic colon cancer," 34th FEBS Congress, 2009

BİŞGİN, ATIL Et Al. "Increased sTRAIL level following BevacizumAb treatment is correlated with patient survival in metastatic colon cancer." 34th FEBS Congress , 2009

BİŞGİN, A. Et Al. (2009) . "Increased sTRAIL level following BevacizumAb treatment is correlated with patient survival in metastatic colon cancer." 34th FEBS Congress .

@conferencepaper{conferencepaper, author={ATIL BİŞGİN Et Al. }, title={Increased sTRAIL level following BevacizumAb treatment is correlated with patient survival in metastatic colon cancer}, congress name={34th FEBS Congress}, city={}, country={}, year={2009}}